Fitzner J, Qasmieh S, Mounts AW, et al. Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection. Bull World Health Organ. 2018;96:122–8. https://doi.org/10.2471/BLT.17.194514.

Article  PubMed  Google Scholar 

Dou L, Reynolds D, Wallace L, et al. Decreased hospital length of stay with early administration of oseltamivir in patients hospitalized with influenza. Mayo Clin Proc Innov Qual Outcomes. 2020;4:176–82. https://doi.org/10.1016/j.mayocpiqo.2019.12.005.

Article  PubMed  PubMed Central  Google Scholar 

Oboho IK, Reed C, Gargiullo P, et al. Benefit of early initiation of influenza antiviral treatment to pregnant women hospitalized with laboratory-confirmed influenza. J Infect Dis. 2016;214:507–15. https://doi.org/10.1093/infdis/jiw033.

Article  PubMed  Google Scholar 

Rodríguez A, Díaz E, Martín-Loeches I, et al. Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A. J Antimicrob Chemother. 2011;66:1140–9. https://doi.org/10.1093/jac/dkq511.

Article  CAS  PubMed  Google Scholar 

Wong CKH, Lau JJ, Au ICH, et al. Optimal timing of nirmatrelvir/ritonavir treatment after COVID-19 symptom onset or diagnosis: target trial emulation. Nat Commun. 2023;14:8377. https://doi.org/10.1038/s41467-023-43706-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Venkatesan S, Myles PR, Bolton KJ, et al. Neuraminidase inhibitors and hospital length of stay: a meta-analysis of individual participant data to determine treatment effectiveness among patients hospitalized with nonfatal 2009 pandemic influenza A(H1N1) virus infection. J Infect Dis. 2020;221:356–66. https://doi.org/10.1093/infdis/jiz152.

Article  CAS  PubMed  Google Scholar 

Katzen J, Kohn R, Houk JL, Ison MG. Early oseltamivir after hospital admission is associated with shortened hospitalization: a 5-year analysis of oseltamivir timing and clinical outcomes. Clin Infect Dis. 2019;69:52–8. https://doi.org/10.1093/cid/ciy860.

Article  CAS  PubMed  Google Scholar 

Lim JK, Kilgore PE, Aiello AE, et al. Impact of time to treatment of oseltamivir on influenza hospitalization cost among Korean children. Pediatr Int. 2015;57:393–400. https://doi.org/10.1111/ped.12526.

Article  PubMed  Google Scholar 

Campbell AP, Tokars JI, Reynolds S, et al. Influenza antiviral treatment and length of stay. Pediatrics. 2021;148:e2021050417. https://doi.org/10.1542/peds.2021-050417.

Article  PubMed  Google Scholar 

Tenforde MW, Noah KP, O’Halloran AC, et al. Timing of influenza antiviral therapy and risk of death in adults hospitalized with influenza-associated pneumonia, FluSurv-NET, 2012–2019. Clin Infect Dis. 2024. https://doi.org/10.1093/cid/ciae427.

Article  PubMed  PubMed Central  Google Scholar 

Kluge S, Janssens U, Welte T, et al. S3-Leitlinie: Empfehlungen zur Therapie von Patienten mit COVID-19. Marburg and Berlin and Köln: AWMF-Institut für Medizinisches Wissensmanagement and Institut für Öffentliches Gesundheitswesen; 2024.

Google Scholar 

European Medicines Agency. Tamiflu. 2023. https://www.ema.europa.eu/en/medicines/human/EPAR/tamiflu. Accessed 18 Jun 2024.

Davies S, Boller E, Chase J, et al. A cost-consequence analysis of the Xpert Xpress CoV-2/Flu/RSV plus test strategy for the diagnosis of influenza-like illnesses. J Med Econ. 2024;27:430–41. https://doi.org/10.1080/13696998.2024.2313391.

Article  PubMed  Google Scholar 

Michiels B, Thomas I, Van Royen P, Coenen S. Clinical prediction rules combining signs, symptoms and epidemiological context to distinguish influenza from influenza-like illnesses in primary care: a cross sectional study. BMC Fam Pract. 2011;12:4. https://doi.org/10.1186/1471-2296-12-4.

Article  PubMed  PubMed Central  Google Scholar 

Lacroix S, Vrignaud B, Avril E, et al. Impact of rapid influenza diagnostic test on physician estimation of viral infection probability in paediatric emergency department during epidemic period. J Clin Virol. 2015;72:141–5. https://doi.org/10.1016/j.jcv.2015.08.002.

Article  PubMed  Google Scholar 

Gentilotti E, De Nardo P, Cremonini E, et al. Diagnostic accuracy of point-of-care tests in acute community-acquired lower respiratory tract infections: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28:13–22. https://doi.org/10.1016/j.cmi.2021.09.025.

Article  PubMed  Google Scholar 

Tenforde MW, Cummings CN, O’Halloran AC, et al. Influenza antiviral use in patients hospitalized with laboratory-confirmed influenza in the United States, FluSurv-NET, 2015–2019. Open Forum Infect Dis. 2023;10:ofac681. https://doi.org/10.1093/ofid/ofac681.

Article  PubMed  Google Scholar 

Rakeman-Cagno JL, Persing DH, Loeffelholz MJ. Maintaining point of care testing capacity and pandemic preparedness in the post-COVID-19 era. Expert Rev Mol Diagn. 2024;24:147–51. https://doi.org/10.1080/14737159.2023.2260743.

Article  CAS  PubMed  Google Scholar 

Jani IV, Peter TF. Nucleic acid point-of-care testing to improve diagnostic preparedness. Clin Infect Dis. 2022;75:723–8. https://doi.org/10.1093/cid/ciac013.

Article  PubMed  PubMed Central  Google Scholar 

Cepheid (2023) Xpert® Xpress CoV-2/Flu/RSV plus: instructions for use. https://www.cepheid.com/content/dam/www-cepheid-com/documents/package-insert-files/xpert-xpress-cov-2-flu-rsv-plus/Xpert%20Xpress%20CoV-2%20FLU%20RSV%20plus%20PI%20302-6991%20Rev.%20B%20EUA.pdf. Accessed 12 Aug 2024.

Destatis. Bevölkerung: Deutschland, Stichtag [result code: 12411-0001]. 2024. https://www-genesis.destatis.de/genesis/online?sequenz=tabelleErgebnis&&selectionname=12411-0001#abreadcrumb. Accessed 17 Sep 2024.

Verband der Ersatzkassen. Daten zum Gesundheitswesen: Versicherte. In: vdek.com. 2024. https://www.vdek.com/presse/daten/b_versicherte.html. Accessed 23 Sep 2024.

Rommel A, von der Lippe E, Treskova-Schwarzbach M, Scholz S. Bevölkerung mit einem erhöhten Risiko für schwere COVID-19-Verläufe in Deutschland: Auswertungen der Studie GEDA 2019/2020-EHIS. J Health Monit. 2021;S2:1–15. https://doi.org/10.25646/7858.3.

Article  Google Scholar 

Goerlitz L, Tolksdorf K, Prahm K, et al. ARE-Konsultationsinzidenz. 2024. https://zenodo.org/records/13841807. Accessed 2 Oct 2024.

Destatis. Bevölkerung: Deutschland, Stichtag, Altersgruppen [result code: 12411-0005]. 2024. https://www-genesis.destatis.de/genesis/online?sequenz=tabelleErgebnis&&selectionname=12411-0005#abreadcrumb. Accessed 17 Sep 2024.

Buda S, Dürrwald R, Biere B, et al. ARE-Wochenbericht KW 09. ARE-Berichterstattung. 2024. https://doi.org/10.25646/11985.

Article  Google Scholar 

Dadashi M, Khaleghnejad S, Abedi Elkhichi P, et al. COVID-19 and influenza co-infection: a systematic review and meta-analysis. Front Med. 2021;8:681469. https://doi.org/10.3389/fmed.2021.681469.

Article  Google Scholar 

Reina J, Dueñas J. Respiratory co-infections between influenza viruses and respiratory syncytial virus (2014–2017). An Pediatr. 2019;90:118–9. https://doi.org/10.1016/j.anpedi.2018.02.011.

Article  Google Scholar 

Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA. 2020;323:2085–6. https://doi.org/10.1001/jama.2020.6266.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Steponavičienė A, Burokienė S, Ivaškevičienė I, et al. Influenza and respiratory syncytial virus infections in pediatric patients during the COVID-19 pandemic: a single-center experience. Children. 2023;10:126. https://doi.org/10.3390/children10010126.

Article  PubMed  PubMed Central  Google Scholar 

Kaiser L, Wat C, Mills T, et al. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med. 2003;163:1667–72. https://doi.org/10.1001/archinte.163.14.1667.

Article  CAS  PubMed  Google Scholar 

CDC. Testing for COVID-19. 2024. https://www.cdc.gov/covid/testing/index.html. Accessed 26 Jul 2024.

Bundeszentrale für gesundheitliche Aufklärung. PCR-test: Goldstandard unter den Corona-Tests. 2023. https://www.infektionsschutz.de/coronavirus/tests-auf-sars-cov-2/pcr-test/. Accessed 17 Sep 2024.

Dugas AF, Valsamakis A, Atreya MR, et al. Clinical diagnosis of influenza in the emergency department. Am J Emerg Med. 2015;33:770–5. https://doi.org/10.1016/j.ajem.2015.03.008.

Article  PubMed  PubMed Central  Google Scholar 

Fragkou PC, Moschopoulos CD, Dimopoulou D, et al. Performance of point-of care molecular and antigen-based tests for SARS-CoV-2: a living systematic review and meta-analysis. Clin Microbiol Infect. 2023;29:291–301. https://doi.org/10.1016/j.cmi.2022.10.028.

Article  CAS  PubMed  Google Scholar 

Smith-Jeffcoat SE, Mellis AM, Grijalva CG, et al. SARS-CoV-2 viral shedding and rapid antigen test performance - respiratory virus transmission network, November 2022–May 2023. MMWR Morb Mortal Wkly Rep. 2024;73:365–71. https://doi.org/10.15585/mmwr.mm7316a2.

Article  CAS